Related references
Note: Only part of the references are listed.Multi-drug Resistance Protein 4 (MRP4/ABCC4) and cyclic nucleotides signaling pathways
Yassine Sassi et al.
CELL CYCLE (2011)
Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors
Estelle Delannoy et al.
CARDIOVASCULAR RESEARCH (2010)
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Marc Humbert et al.
CIRCULATION (2010)
Novel Strategy for Treatment of Pulmonary Arterial Hypertension: Enhancement of Apoptosis
Jing-bin Huang et al.
LUNG (2010)
Emerging therapies for the treatment of pulmonary hypertension
Kurt R. Stenmark et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial (vol 149, pg 521, 2008)
G. Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2009)
Tadalafil Therapy for Pulmonary Arterial Hypertension
Nazzareno Galie et al.
CIRCULATION (2009)
Interleukin-6 Overexpression Induces Pulmonary Hypertension
M. Kathryn Steiner et al.
CIRCULATION RESEARCH (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Simvastatin and sildenafil combine to attenuate pulmonary hypertension
L. Zhao et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs
Lena Oevermann et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Future Perspectives for the Treatment of Pulmonary Arterial Hypertension
Hossein A. Ghofrani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Paul M. Hassoun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Phosphodiesterase Type 5 Inhibitors for Pulmonary Arterial Hypertension.
Stephen L. Archer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension
Reshma S. Baliga et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export
Cornelius F. H. Mueller et al.
CIRCULATION (2008)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2008)
Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation
Yassine Sassi et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
Gerald Simonneau et al.
ANNALS OF INTERNAL MEDICINE (2008)
Spatiotemporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia
Chunying Li et al.
CELL (2007)
Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway
Jonathan M. Maher et al.
HEPATOLOGY (2007)
The effects of hypoxia on the cells of the pulmonary vasculature
O. Pak et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility
Jayan Nagendran et al.
CIRCULATION (2007)
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension target for reverse-remodeling therapy
Ralph Theo Schermuly et al.
CIRCULATION (2007)
Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1
Fiona Murray et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries
Lise Rodat et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Drug combination treatment for pulmonary arterial hypertension
H. A. Ghofrani et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia
Fleur Fresquet et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins
Roger G. Deeley et al.
PHYSIOLOGICAL REVIEWS (2006)
Rho kinases in cardiovascular physiology and pathophysiology
G Loirand et al.
CIRCULATION RESEARCH (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells
J Wharton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Endothelial dysfunction in pulmonary hypertension
R Budhiraja et al.
CIRCULATION (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension
HA Ghofrani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells
T Nishimura et al.
CIRCULATION (2003)
Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells
S Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
G Reid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension
HA Ghofrani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension
A Sebkhi et al.
CIRCULATION (2003)
Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells
PR Wielinga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5
G Reid et al.
MOLECULAR PHARMACOLOGY (2003)
Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis
P Sinnaeve et al.
CIRCULATION (2002)
Transport of cyclic nucleotides and estradiol 17-β-D-glueuronide by multidrug resistance protein 4 -: Resistance to 6-mercaptopurine and 6-thioguanine
ZS Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
Sildenafil inhibits hypoxia-induced pulmonary hypertension
L Zhao et al.
CIRCULATION (2001)
A family of drug transporters: The multidrug resistance-associated proteins
P Borst et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
MM Hoeper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)